These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25677664)

  • 21. Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
    Jia Y; Hoang MH; Jun HJ; Lee JH; Lee SJ
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4185-90. PubMed ID: 23769638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Spiro[pyrrolidine-3,3'-oxindole] LXRβ Agonists for the Treatment of Osteoporosis.
    Chen H; Hua P; Huang D; Zhang Y; Zhou H; Xu J; Gu Q
    J Med Chem; 2023 Jan; 66(1):752-765. PubMed ID: 36539349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
    Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
    Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR
    Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice.
    Korach-André M; Parini P; Larsson L; Arner A; Steffensen KR; Gustafsson JA
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E167-78. PubMed ID: 19690071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A liver-selective LXR inverse agonist that suppresses hepatic steatosis.
    Griffett K; Solt LA; El-Gendy Bel-D; Kamenecka TM; Burris TP
    ACS Chem Biol; 2013 Mar; 8(3):559-67. PubMed ID: 23237488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting liver X receptors in human health: deadlock or promising trail?
    Viennois E; Pommier AJ; Mouzat K; Oumeddour A; El Hajjaji FZ; Dufour J; Caira F; Volle DH; Baron S; Lobaccaro JM
    Expert Opin Ther Targets; 2011 Feb; 15(2):219-32. PubMed ID: 21204733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.
    Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S
    J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists.
    Nian S; Gan X; Tan X; Yu Z; Wang P; Chen X; Wang G
    Chem Pharm Bull (Tokyo); 2015; 63(8):628-35. PubMed ID: 26062802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
    Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
    Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fragment-based approach for ligand binding affinity and selectivity for the liver X receptor beta.
    Salum LB; Andricopulo AD; Honório KM
    J Mol Graph Model; 2012 Feb; 32():19-31. PubMed ID: 22030023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.
    Nomura S; Endo-Umeda K; Fujii S; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2018 Feb; 28(4):796-801. PubMed ID: 29398545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame?
    Degirolamo C; Moschetta A
    J Intern Med; 2012 Nov; 272(5):449-51. PubMed ID: 22651910
    [No Abstract]   [Full Text] [Related]  

  • 37. Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases.
    Warner M; Gustafsson JA
    Mol Psychiatry; 2015 Feb; 20(1):18-22. PubMed ID: 24662928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A de novo substructure generation algorithm for identifying the privileged chemical fragments of liver X receptorβ agonists.
    Peng H; Liu Z; Yan X; Ren J; Xu J
    Sci Rep; 2017 Sep; 7(1):11121. PubMed ID: 28894088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of a Potent TLX Agonist by Rational Fragment Fusion.
    Faudone G; Zhubi R; Celik F; Knapp S; Chaikuad A; Heering J; Merk D
    J Med Chem; 2022 Feb; 65(3):2288-2296. PubMed ID: 34989568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular modeling of interaction of 17(20)Z- and 17(20)E-pregna-5,17(20)-dien-21-oyl amides with the nuclear receptor LXRbeta].
    Fediushkina IV; Stulov SV; Dugin NO; Misharin AIu; Mekhtiev AR; Morozevich GE; Veselovskiĭ AV
    Biomed Khim; 2013; 59(3):321-9. PubMed ID: 23987069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.